AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Aug 4, 2021
29821_dirs_2021-08-04_82b78805-df36-4111-8457-065e1675ad56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-08-02
Reporting Person: Scanlon Meghan (SVP,Pres,Urology Pelvic Health)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | Restricted Stock Units | $ | A | 15257.0000 | Acquired | 2025-08-02 | Common Stock (15257.0000) | Direct |
Footnotes
F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2